259 results
8-K
EX-99.1
AMPE
Ampio Pharmaceuticals Inc
11 Jan 24
Ampio Provides Litigation Update Reports Settlement in Principle of Certain Pending Legal Actions
4:20pm
Exhibit 99.1
Ampio Provides Litigation Update
Reports Settlement in Principle of Certain Pending Legal Actions
ENGLEWOOD, Colo., January 11, 2024 … 2023CV30287, as well as two stockholders who previously submitted pre-litigation demand letters to the Company’s Board of Directors.
Ampio currently
8-K
EX-99.1
AMPE
Ampio Pharmaceuticals Inc
16 May 22
Results of Operations and Financial Condition
12:00am
contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any … investigation, any related litigation and compliance with FDA and SEC requirements; and (c) the actual and perceived effectiveness of Ampion, and how Ampion
8-K
sa5zsohtyvmfyzb6h
9 Jan 12
Regulation FD Disclosure
12:00am
8-K
9o4ruq 804
1 Jul 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
a07uxx
10 Nov 21
Further details to be discussed on this afternoon’s conference call
4:05pm
8-K
EX-99.1
nr36oaa
4 Aug 21
Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:06pm
424B5
np7sg1gc5
6 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
z9ye ojo6
18 Nov 22
Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension
4:26pm
8-K
EX-99.1
gypl560f x3dp
30 Apr 19
Ampio Pharmaceuticals Provides Regulatory Update
8:30am
8-K
EX-99.1
kb5v94c
21 Dec 11
Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
12:00am
424B5
pa4 6s01q64qdv
24 Jan 24
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
efkqs5s2rcna
20 May 11
Ampio Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Capital Market
12:00am